Mantis Robotics Raises $5M to Advance Human-Centric Robots

Mantis Robotics, a pioneer in Physical AI for robotic automation, today announced it has secured $5M in new investments led by Emerald Technology Ventures with participation from the Amazon Industrial Innovation Fund. This cash infusion will enable Mantis Robotics to scale its operations, enhance its product portfolio, and expand its presence in the rapidly growing industrial robotics market.

Mantis has entered the next frontier in robotics by creating the first adaptive, human-centered robots. The company makes industrial robotic arms that are inherently safe for human interaction, eliminating the need for costly and complex external safeguards such as fences or laser barriers. Mantis’ technology learns and understands its environment based on sensor data from a proprietary built-in sensor-suite. This enables Mantis Robots to detect obstacles and humans in its direct environment and adjust the robot’s behavior accordingly in real-time, making robot arms safe and autonomous.

The robot’s intuitive deployment software with 3D real-time Digital Twin, requires no technical or coding knowledge to use, making them accessible for diverse industries and users. By reducing operational complexity, Mantis’ robot systems can result in savings of as much as 75% in a typical robotic deployment. The company’s transformative technology has the potential to advance industries far beyond manufacturing and warehousing, paving the way for a new era of human-machine collaboration.

“We built our company on the premise that robots should be an extension of human capability,” said Gerry Vannuffelen, Founder & CEO of Mantis Robotics. “Our industry has benefited greatly from many new developments in AI-powered application software. Unfortunately, these systems do not allow for safe human-robot interaction. We provide the link between AI and the physical world, by enabling robots to interact safely and capably with humans.”

“The investment into Mantis Robotics is another bet of Emerald on the huge potential of Physical AI. We believe Mantis Robotics’ unique technology will revolutionize robotics and will enable never-seen before levels of human-machine collaboration. Mantis Robotics unlocks entirely new automation use cases initially in manufacturing and in warehousing, and in soon virtually every other domain,” said Michal Natora, Senior Investment Director at Emerald.

“At Amazon, collaborative technology is key to running safe and efficient operations. Technology can serve its best purpose when it’s human-centric and able to work seamlessly to support employees as they deliver for our customers,” said Franziska Bossart, Head of the Amazon Industrial Innovation Fund. “We are excited about Mantis Robotics’ science-driven approach to advancing human-machine collaboration, fostering safer and more ergonomic workplaces.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mantis Robotics, Inc.. (2024, December 17). Mantis Robotics Raises $5M to Advance Human-Centric Robots. AZoRobotics. Retrieved on December 17, 2024 from https://www.azorobotics.com/News.aspx?newsID=15574.

  • MLA

    Mantis Robotics, Inc.. "Mantis Robotics Raises $5M to Advance Human-Centric Robots". AZoRobotics. 17 December 2024. <https://www.azorobotics.com/News.aspx?newsID=15574>.

  • Chicago

    Mantis Robotics, Inc.. "Mantis Robotics Raises $5M to Advance Human-Centric Robots". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=15574. (accessed December 17, 2024).

  • Harvard

    Mantis Robotics, Inc.. 2024. Mantis Robotics Raises $5M to Advance Human-Centric Robots. AZoRobotics, viewed 17 December 2024, https://www.azorobotics.com/News.aspx?newsID=15574.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.